Amen Clinics

Last updated
Amen Clinics
Founded1989 (1989)
Founder Daniel G. Amen
Headquarters
United States
Area served
 Newport Beach, California, San Francisco, California, Atlanta, Georgia, Reston, Virginia, Bellevue, Washington, New York City
Website www.amenclinics.com

Amen Clinics is a group of mental and physical health clinics that work on the treatment of mood and behavior disorders. It was founded in 1989 by Daniel G. Amen, a self-help author and psychiatrist. [1] [2] The clinics perform clinical evaluations and brain SPECT (single photon emission computed tomography) imaging to diagnose and treat their patients. [3] [4] Amen Clinics uses SPECT scans, a type of brain-imaging technology, to measure neural activity through blood flow. [5] [6] It has a database of more than 100,000 functional brain scans from patients in 111 countries, [7] and several locations throughout the United States. [4] [8] The American Psychiatric Association has criticized the clinical appropriateness of Amen's use of brain scans, and in 2006 published a statement saying that "the clinical utility of neuroimaging techniques for planning of individualized treatment has not yet been shown". [9]

Contents

Operations

Amen Clinics was founded in 1989. It has been using brain SPECT in an attempt to diagnose and treat psychiatric illness since 1991. [10] Amen Clinics incorporates questionnaires, clinical histories, and clinical interviews in its practice. [5] [11] Some Amen Clinics locations also use quantitative electroencephalography as a diagnostic tool. [12] Amen Clinics has scanned 50,000 people, at an estimated cost of $170 million, according to Daniel Amen. [13]

As of 2014, Amen Clinics had a database of more than 100,000 functional brain scans. [7] The subjects are from 111 countries with ages from 9 months to 101 years old. [7] The database was funded in part by Seeds Foundation in Hong Kong, and developed by Daniel Amen with a team of researchers including Kristen Willeumier. [7] Amen Clinics has treated numerous former athletes, including NFl players. [14] [15] Some researchers and physicians have said that evidence for the efficacy of the methods in which the clinic uses SPECT is unclear or absent. [16] [17] [18] [9] [13]

Ethics

This section is an excerpt from Daniel Amen § Ethics of SPECT scanning.[ edit ]

Questions have been raised about the ethics of selling SPECT scans on the basis of unproven claims: neuroscience professor Martha Farah calls such use "profitable but unproven" and says, "Tens of thousands of individuals, many of them children, have been exposed to the radiation of two SPECT scans and paid thousands of dollars out of pocket (because insurers will not pay) against the advice of many experts". [19] Professor of psychology Irving Kirsch has said of Amen's theory: "Before you start promulgating this and marketing it and profiting from it, you should ethically be bound to demonstrate it scientifically in a peer-reviewed, respected journal", as otherwise, "you're just going down the path of being a snake oil salesman". [20] In a 2011 paper, neuroscientist Anjan Chatterjee discussed example cases that were found on the Amen Clinic's website, including a couple with marital difficulties and a child with impulsive aggression. The paper noted that the examples "violate the standard of care" because a normal clinical diagnosis would have been sufficient and that there "was no reason to obtain functional neuroimaging for diagnostic purposes in these cases." [21] Most patients do not realize that the SPECT scans rely on unproven claims. [22] In 2021, Steven Hyman, director of the Stanley Center for Psychiatric Research, stated, "people who are desperate are vulnerable to snake oil, and this has all of the look and feel of a clinic that's preying on people's desperation." [23] [24]

An initial evaluation with SPECT at Amen's clinics cost about $4,000 in 2020. [25] As reported by The Washington Post in 2012, officials at major psychiatric and neuroscience associations and research centers see Amen's claims for the use of SPECT as "no more than myth and poppycock, buffaloing an unsuspecting public." [20]

Related Research Articles

<span class="mw-page-title-main">Single-photon emission computed tomography</span> Nuclear medicine tomographic imaging technique

Single-photon emission computed tomography is a nuclear medicine tomographic imaging technique using gamma rays. It is very similar to conventional nuclear medicine planar imaging using a gamma camera, but is able to provide true 3D information. This information is typically presented as cross-sectional slices through the patient, but can be freely reformatted or manipulated as required.

In philosophy and neuroscience, neuroethics is the study of both the ethics of neuroscience and the neuroscience of ethics. The ethics of neuroscience concerns the ethical, legal, and social impact of neuroscience, including the ways in which neurotechnology can be used to predict or alter human behavior and "the implications of our mechanistic understanding of brain function for society... integrating neuroscientific knowledge with ethical and social thought".

Neuroimaging is a medical technique that allows doctors and researchers to take pictures of the inner workings of the body or brain of a patient. It can show areas with heightened activity, areas with high or low blood flow, the structure of the patients brain/body, as well as certain abnormalities. Neuroimaging is most often used to find the specific location of certain diseases or birth defects such as tumors, cancers, or clogged arteries. Neuroimaging first came about as a medical technique in the 1880s with the invention of the human circulation balance and has since lead to other inventions such as the x-ray, air ventriculography, cerebral angiography, PET/SPECT scans, magnetoencephalography, and xenon CT scanning.

Neurotechnology encompasses any method or electronic device which interfaces with the nervous system to monitor or modulate neural activity.

<span class="mw-page-title-main">Institute of Psychiatry, Psychology and Neuroscience</span> Research institution in London, England

The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is a centre for mental health and neuroscience research, education and training in Europe. It is dedicated to understanding, preventing and treating mental illness, neurological conditions, and other conditions that affect the brain. The IoPPN is a faculty of King's College London, England, and was previously known as the Institute of Psychiatry (IoP).

Neuropsychiatry is a branch of medicine that deals with psychiatry as it relates to neurology, in an effort to understand and attribute behavior to the interaction of neurobiology and social psychology factors. Within neuropsychiatry, the mind is considered "as an emergent property of the brain", whereas other behavioral and neurological specialties might consider the two as separate entities. Those disciplines are typically practiced separately.

Eve Cordelia Johnstone CBE FRCP FRCPE FRCPGla FRCPsych FMedSci FRSE is a Scottish physician, clinical researcher, psychiatrist and academic. Her main research area is in the field of schizophrenia and psychotic illness. She is emeritus Professor of Psychiatry and Honorary Assistant Principal for Mental Health Research Development and Public Understanding of Medicine at the University of Edinburgh. She is best known for her 1976 groundbreaking study that showed brain abnormalities in schizophrenic patients compared to a control group.

<span class="mw-page-title-main">Neuroimaging</span> Set of techniques to measure and visualize aspects of the nervous system

Neuroimaging is the use of quantitative (computational) techniques to study the structure and function of the central nervous system, developed as an objective way of scientifically studying the healthy human brain in a non-invasive manner. Increasingly it is also being used for quantitative research studies of brain disease and psychiatric illness. Neuroimaging is highly multidisciplinary involving neuroscience, computer science, psychology and statistics, and is not a medical specialty. Neuroimaging is sometimes confused with neuroradiology.

<span class="mw-page-title-main">Daniel Amen</span> American celebrity doctor

Daniel Gregory Amen is an American celebrity doctor who practices as a psychiatrist and brain disorder specialist. He is the founder and chief executive officer (CEO) of the Amen Clinics. He is also the founder of Change Your Brain Foundation, BrainMD, and Amen University. Discover Magazine recognized Amen's research on PTSD and Traumatic Brain Injury (TBI) as one of the top 100 science stories of 2015. He is a twelve-time New York Times best-selling author as of 2023.

<span class="mw-page-title-main">Psychiatry</span> Branch of medicine devoted to mental disorders

Psychiatry is the medical specialty devoted to the diagnosis, prevention, and treatment of deleterious mental conditions. These include various matters related to mood, behaviour, cognition, perceptions, and emotions.

<span class="mw-page-title-main">Anjan Chatterjee (neuroscientist)</span> American neurologist (born 1958)

Anjan Chatterjee is a professor of neurology at the Perelman School of Medicine at the University of Pennsylvania. He is director of the Penn Center for Neuroaesthetics (PCfN) and a member of the Center for Cognitive Neuroscience. His research focuses on spatial cognition and its relationship to language. He also conducts neuroaesthetics research and writes about the ethical use of neuroscience findings in society.

<span class="mw-page-title-main">Brain positron emission tomography</span> Form of positron emission tomography

Brain positron emission tomography is a form of positron emission tomography (PET) that is used to measure brain metabolism and the distribution of exogenous radiolabeled chemical agents throughout the brain. PET measures emissions from radioactively labeled metabolically active chemicals that have been injected into the bloodstream. The emission data from brain PET are computer-processed to produce multi-dimensional images of the distribution of the chemicals throughout the brain.

The delayed-maturation theory of obsessive–compulsive disorder suggests that obsessive–compulsive disorder (OCD) can be caused by delayed maturation of the frontal striatal circuitry or parts of the brain that make up the frontal cortex, striatum, or integrating circuits. Some researchers suspect that variations in the volume of specific brain structures can be observed in children that have OCD. It has not been determined if delayed-maturation of this frontal circuitry contributes to the development of OCD or if OCD is the ailment that inhibits normal growth of structures in the frontal striatal, frontal cortex, or striatum. However, the use of neuroimaging has equipped researchers with evidence of some brain structures that are consistently less adequate and less matured in patients diagnosed with OCD in comparison to brains without OCD. More specifically, structures such as the caudate nucleus, volumes of gray matter, white matter, and the cingulate have been identified as being less developed in people with OCD in comparison to individuals that do not have OCD. However, the cortex volume of the operculum (brain) is larger and OCD patients are also reported to have larger temporal lobe volumes; which has been identified in some women patients with OCD. Further research is needed to determine the effect of these structural size differences on the onset and degree of OCD and the maturation of specific brain structures.

<span class="mw-page-title-main">Katya Rubia</span> British neuroscentist

Katya Rubia is a professor of Cognitive Neuroscience at the MRC Social, Genetic and Developmental Psychiatry Centre and Department of Child and Adolescent Psychiatry, both part of the Institute of Psychiatry, King's College London.

<span class="mw-page-title-main">Rajendra Badgaiyan</span> American physician

Professor Rajendra D Badgaiyan is an Indian-American psychiatrist and cognitive neuroscientist. He is best known for developing a new neuroimaging technique for detection of acute changes in concentration of dopamine released in the live human brain during performance of a cognitive, behavioral, or emotional task.

<span class="mw-page-title-main">Andrew J. Gerber</span>

Andrew J. Gerber is an American psychoanalyst and the current president and medical director of Silver Hill Hospital in New Canaan, Connecticut. His principal interests and research lie in studying the neurobiological bases of social cognition, particularly in relation to autism spectrum disorders and change in response to psychotherapy. He is a member of the American Academy of Child and Adolescent Psychiatry, American Psychiatric Association, American Psychoanalytic Association and the Psychoanalytic Psychodynamic Research Society.

<span class="mw-page-title-main">Lori L. Altshuler</span> American psychiatrist (1957–2015)

Lori Altshuler was a professor at the University of California, Los Angeles (UCLA) Department of Psychiatry and Biobehavioral Sciences and held the Julia S. Gouw Endowed Chair for Mood Disorders. Altshuler was the Director of the UCLA Mood Disorders Research Program and the UCLA Women's Life Center, each being part of the Neuropsychiatric Hospital at UCLA.

Philip F. Cohen is a Canadian clinical director of Nuclear Medicine working out of the Lions Gate Hospital in North Vancouver, British Columbia. As a nuclear medicine physician, he is a pioneer in the usage of 3-D imaging techniques to improve diagnosis of bone disease and injury in collaboration with the Medical Imaging Research Group at University of British Columbia. Furthermore, Cohen has been involved in clinical research trials of new radiopharmaceuticals. To that effect, Cohen was the first recipient of a research grant from the Lions Gate Hospital Foundation, one of several peer-reviewed awards that would follow.

<span class="mw-page-title-main">Ganesan Venkatasubramanian</span> Indian psychiatrist and clinician

Ganesan Venkatasubramanian is an Indian psychiatrist and clinician-scientist who works as a professor of psychiatry at the National Institute of Mental Health and Neurosciences, Bangalore (NIMHANS). His overarching research interest to learn the science that will facilitate a personalized approach to understand and treat severe mental disorders like schizophrenia. Venkatasubramanian is known for his studies in the fields of schizophrenia, transcranial Direct Current Stimulation (tDCS), brain imaging, neuroimmunology, neurometabolism and several other areas of biological psychiatry. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, for his contributions to medical sciences in 2018. He was also one of the collaborating scientists in the NIMHANS-IOB Bioinformatics and Proteomics laboratory of the Institute of Bioinformatics (IOB) in Bangalore and NIMHANS. Besides, he is an adjunct faculty at the Centre for Brain Research (CBR) in Bangalore.

Scott Laurence Rauch is the President, Psychiatrist in Chief, and Rose Marie and Eijk van Otterloo Chair of Psychiatry of McLean Hospital, who is known for his work using brain imaging methods to study psychiatric dysfunction. He is a professor of psychiatry at Harvard Medical School.

References

  1. ↑ James Butcher (2008). "Neuropolitics gone mad". The Lancet Neurology. 7 (4): 295. doi:10.1016/S1474-4422(08)70056-5. S2CID   54411790.
  2. ↑ "License Information". Medical Board of California. Retrieved November 7, 2012.
  3. ↑ Dawn Ford (October 9, 2012). "The Seniors' Situation Room Edition 5 by Dawn Ford". Cornwall Free News. Retrieved November 7, 2012.
  4. 1 2 Everett Catts (October 18, 2012). "Brain expert speaks in Buckhead, opens Sandy Springs clinic". Neighbor Newspapers. Retrieved November 7, 2012.
  5. 1 2 Daniel Carlat (May 19, 2008). "Brain Scans as Mind Readers? Don't Believe the Hype". Wired. Retrieved November 7, 2012.
  6. ↑ Daniel G Amen; Manuel Trujillo; Barry Chaitin (2011). "Brain SPECT Imaging in Complex Psychiatric Cases: An Evidence-Based, Underutilized Tool". Open Neuroimaging Journal. 5: 40–8. doi:10.2174/1874440001105010040. PMC   3149839 . PMID   21863144.
  7. 1 2 3 4 Kathy Mahdoubi (13 October 2014). "New SPECT database holds 100K scans for psychiatric study". Molecular Imaging. Retrieved 19 February 2015.
  8. ↑ "Amen Clinics & Brain Spect Imaging". Brain World Magazine. October 25, 2012. Retrieved October 9, 2013.
  9. 1 2 American Psychiatric Association (2006). American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. American Psychiatric Pub. p. 44. ISBN   978-0-89042-385-1.
  10. ↑ Daniel G. Amen (26 April 2010). "Change Your Brain, Change Your Body". The Huffington Post. Retrieved 3 February 2015.
  11. ↑ Eliza Shapiro (14 December 2012). "Can Daniel Amen Read Your Mind?". The Daily Beast. Retrieved 3 February 2015.
  12. ↑ Zoë Kessler (2014). "Shawn Ladd's Excellent Amen Clinics Adventure – Part I". Psych Central. Retrieved 3 February 2015.
  13. 1 2 Chancellor, B.; Chatterjee, A. (2011). "Brain Branding: When Neuroscience and Commerce Collide". AJOB Neuroscience. 2 (4): 18–27. doi:10.1080/21507740.2011.611123. S2CID   17157310.
  14. ↑ Leigh Steinberg (3 September 2013). "Death of the NFL: Part 2". Forbes . Retrieved 19 February 2015.
  15. ↑ Rick Maese (7 June 2012). "NFL concussions lawsuits aim to improve the damaged brain". The Washington Post . Retrieved 19 February 2015.
  16. ↑ Adinoff, Bryon; Devous, Michael (1 Sep 2010). "Response to Amen Letter". The American Journal of Psychiatry. 167 (9). American Psychiatric Association. doi:10.1176/appi.ajp.2010.10050671 (inactive 2024-08-27).{{cite journal}}: CS1 maint: DOI inactive as of August 2024 (link)
  17. ↑ Hall, Harriet (8 April 2008). "SPECT Scans at the Amen Clinic – A New Phrenology?". Science-Based Medicine. Retrieved 3 October 2013.
  18. ↑ Harriet Hall, M.D. (15 November 2007). "A Skeptical View of SPECT Scans and Dr. Daniel Amen" . Retrieved 3 October 2013.
  19. ↑ Farah, M.J. (2009). "A picture is worth a thousand dollars". Journal of Cognitive Neuroscience (Editorial). 21 (4): 623–4. doi:10.1162/jocn.2009.21133. PMID   19296729. S2CID   29300297.
  20. 1 2 Tucker, Neely (August 9, 2012). "Daniel Amen is the most popular psychiatrist in America. To most researchers and scientists, that's a very bad thing". Washington Post Magazine .
  21. ↑ Chancellor, B.; Chatterjee, A. (2011). "Brain branding: When neuroscience and commerce collide". AJOB Neuroscience. 2 (4): 18. doi:10.1080/21507740.2011.611123. S2CID   17157310. Amen Clinics, Inc., has scanned more than 50,000 patients at a cost close to $170 million.
  22. ↑ Farah, Martha J.; Gillihan, Seth J. (2013). "Ch. 11 Neuroimaging in Clinical Psychiatry". In Chatterjee, Anjan; Farah, Martha J. (eds.). Neuroethics in Practice. Oxford University Press. pp.  131–143. ISBN   978-0-19-538978-4.
  23. ↑ Medaris, Anna (27 January 2022). "A controversial Hollywood psychiatrist conducted Bella Hadid's brain scans, inspiring the model to stop drinking". Insider. Retrieved 26 May 2022.
  24. ↑ "People who think they have CTE are seeking treatment at a controversial brain clinic". NPR.org. 23 November 2021. Retrieved 26 May 2022.
  25. ↑ Nagappan, Ashwini; Kalokairinou, Louiza; Wexler, Anna (October 2021). "Ethical and Legal Considerations of Alternative Neurotherapies". AJOB Neuroscience. 12 (4): 257–269. doi:10.1080/21507740.2021.1896601. ISSN   2150-7740. PMC   8460707 . PMID   33759705.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.